This topic contains 0 replies, has 1 voice, and was last updated by  Charlene Marshall 1 month, 3 weeks ago.

  • Author
  • #20076
     Charlene Marshall 

    The prognosis remains poor for patients living with idiopathic pulmonary fibrosis (IPF) and collaborations to enhance and expedite treatment options are crucial to patient survival. A recent collaboration has been announced by AstraZeneca to speed the discovery of new medicines for IPF, which is discussed in our latest flash briefing. To listen to the full briefing, click HERE.

    What are your thoughts on this flash briefing?

    An interesting, but complex and seemingly promising advancement for those of us living with IPF!

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account